CBP/p300 proteins have an oncogenic role in PCa in a cellular context‐dependent manner (Ding et al, 2014; Zhong et al, 2014), consistent with the finding that p300 is often deregulated in PCa patient samples (Debes et al, 2003). Here, EP300 is linked to posterior cortical atrophy.